Mitigating Drug Shortages
Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.
In this exclusive PC Podcast interview, Allen Jacques, a life sciences industry thought leader at Kinaxis, dives into:
- What he sees as limitations of current government efforts when it comes to boosting domestic production of essential medicines, and why they aren’t sufficient
- How and why drug shortages occur
- The challenges that generic drug manufacturers are facing today
- Why more resilient and transparent supply chains are necessary in the pharmaceutical industry, and how these can help mitigate shortage issues
The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.
Recent Videos
Related Content
The Biosimilars Landscape Through the Eyes of an Economist
February 21st 2025Article
James D. Chambers, PhD, MPharm, MSc, professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, dives into why biosimilars contribute to a reduction in cost and increase in patient access, while highlighting challenges to adoption.
